If a patient had AML and developed Sweet's Syndrome, should that be reported on the Pre-TED as a comorbidity?
No, Sweet Syndrome would not be reported anywhere on the Pre-TED as it is associated with AML.
What if the patient has MDS that transformed to AML, should the MDS be reported as a comorbidity?
No, MDS is also a disease process of AML, so it is not considered a comorbidity.
Comorbid conditions that should be reported on the Pre-TED are diseases or organ impairments, that the patient is currently under treatment for at the time of HCT, or, are of a severity to potentially threaten the patient's ability to endure the transplant and crucial recovery time, such as:
- Diabetes (do not report if treated with diet alone)
- Renal insufficiency on dialysis, or with a creatinine>2.0 mg/dL
- Hepatitis B & C (should be reported as "hepatic, mild" comorbidity, even if not under treatment at the time of HCT.
- TB; and HIV (should be reported as an "infection" comorbidity).
- A subarachnoid hemorrhage (not subdural hemorrhage) or stroke at any time in a patient's history should be reported as a "cerebrovascular" comorbidity.
While, in contrast, these conditions in a patient's history would not qualify as comorbities: GERD, DVT, Pulmonary emboli, MRSA, epilepsy, Cerebral Palsy, Hepatitis A, psoriasis, and EBV.
The above mentioned conditions are examples, you can access more information through this reference: Appendix U from the Data Management Manual on our website www.cibmtr.org.